Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Graminn
- Development stage
- Unknown
- Lead developer
- INNventa Pharm
- Administration
- Oral
01
Overview
Graminn is a dietary supplement developed and marketed by INNventa Pharm, specifically formulated for the management of urological conditions such as benign prostatic hyperplasia (BPH) and chronic prostatitis. The active ingredient in Graminn is **Graminex G63**, a standardized flower pollen extract derived from rye (*Secale cereale*). This extract contains both water-soluble and fat-soluble fractions of pollen, which are thought to exert anti-inflammatory, anti-edematous, and spasmolytic effects on the prostate and urinary tract. Graminn is used to alleviate lower urinary tract symptoms (LUTS), including frequent urination, nocturia, and weak urinary flow, by reducing prostate swelling and relaxing the smooth muscles of the urethra.
- Brand names
- Graminn
- Other names
- Graminex G63Flower pollen extractSecale cereale pollen extractCernilton
02
Targets
CysLTR (Cysteinyl leukotriene receptor family)
Beyond the preview
Go deeper on Graminn.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Graminn.